Fakultni nemocnice Olomouc ( Site 0701)

Olomouc 779 00

1 studies enrolling now · 2 studies all time

What they study most

Head and Neck Neoplasms, Hematologic Malignancies, Solid Tumors

Studies at this site

• Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) — Recruiting now
• Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) — Completed